Vaporized cannabis versus placebo for acute migraine: A randomized, double‐blind, placebo‐controlled crossover trial is a research paper published in Headache The Journal of Head and Face Pain (2025). On theSindex it has a DataRank of 0.165. It has been cited 2 times, with 2 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.165
From this paper's citation signal
Citation Network Contribution
0
From 0 citing papers with measurable signal
This paper's DataRank is currently driven only by its base citation score. None of the citing papers had measurable citation signal.
Learn more about DataRank methodology →National Institutes of Health
Grant: UL1TR001442
NCCIH NIH HHS
Grant: R00 AT009466
NINDS NIH HHS
Grant: U24 NS115714
NINDS NIH HHS
Grant: OT2 NS122680
NCATS NIH HHS
Grant: UL1 TR000100
Academic Senate, University of California, San Diego
Academic Senate, University of California, Riverside
Migraine Research Foundation
MeSH Terms
Keywords